Literature DB >> 14698582

Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers.

Omathanu Pillai1, Vinod Nair, Ramesh Panchagnula.   

Abstract

Transdermal iontophoresis per se may not be able to achieve significant permeation of large peptides like insulin, thereby necessitating the use of combination strategies involving chemical enhancers and iontophoresis. The study investigated effect of pre-treatment with commonly used vehicles such as ethanol (EtOH), propylene glycol (PG), water and their binary combinations, dimethyl acetamide (DMA), 10% dimethyl acetamide in water, ethyl acetate (EtAc) and isopropyl myristate (IPM) on insulin iontophoresis. Solvents, which acted on the lipid bilayer, were able to produce a synergistic enhancement with iontophoresis. The binary solvent systems produced either additive or no effect, when combined with iontophoresis. FT-IR studies showed that EtOH, DMA, EtAc caused lipid extraction and the former two also caused changes in skin proteins, whereas IPM caused increase in lipid fluidity. TGA studies showed that EtOH and PG caused dehydration of skin. Skin barrier property was severely compromised with DMA, followed by EtOH and EtAc, while IPM and PG had relatively minimum skin barrier altering potential. Thus, this study demonstrates the possibility of achieving higher permeation of large peptides like insulin by combining iontophoresis with chemical enhancers that act on the intercellular lipids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698582     DOI: 10.1016/j.ijpharm.2003.09.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Machine learning study for the prediction of transdermal peptide.

Authors:  Eunkyoung Jung; Seung-Hoon Choi; Nam Kyung Lee; Sang-Kee Kang; Yun-Jaie Choi; Jae-Min Shin; Kihang Choi; Dong Hyun Jung
Journal:  J Comput Aided Mol Des       Date:  2011-03-30       Impact factor: 3.686

2.  A skin permeability model of insulin in the presence of chemical penetration enhancer.

Authors:  K M Yerramsetty; B J Neely; S V Madihally; K A M Gasem
Journal:  Int J Pharm       Date:  2009-12-21       Impact factor: 5.875

3.  Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.

Authors:  Luciana B Lopes; Colleen M Brophy; Elizabeth Furnish; Charles R Flynn; Olivia Sparks; Padmini Komalavilas; Lokesh Joshi; Alyssa Panitch; M Vitoria L B Bentley
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

4.  Iontophoretic permeation of lisinopril at different current densities and drug concentrations.

Authors:  Ashish Jain; Satish Nayak; Vandana Soni
Journal:  Adv Pharm Bull       Date:  2012-08-15

Review 5.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

6.  Effect of different enhancers on the transdermal permeation of insulin analog.

Authors:  K M Yerramsetty; V K Rachakonda; B J Neely; S V Madihally; K A M Gasem
Journal:  Int J Pharm       Date:  2010-08-03       Impact factor: 5.875

Review 7.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

8.  Transdermal delivery by iontophoresis.

Authors:  Swati Rawat; Sudha Vengurlekar; B Rakesh; S Jain; G Srikarti
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

9.  Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery.

Authors:  Jadupati Malakar; Suma Oomen Sen; Amit Kumar Nayak; Kalyan Kumar Sen
Journal:  Saudi Pharm J       Date:  2012-02-21       Impact factor: 4.330

10.  Effect of vehicles on the maximum transepidermal flux of similar size phenolic compounds.

Authors:  Qian Zhang; Peng Li; David Liu; Michael S Roberts
Journal:  Pharm Res       Date:  2012-08-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.